Neurogene Inc (NGNE): Hedge Fund Ownership & Smart Money Signals (Q1 2026)

Q: Is it too late to buy Neurogene Inc (NGNE) following the 2026 Q1 hedge fund 13F filings?

As of today, NGNE has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), NGNE gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Neurogene Inc (NGNE)

96 + Investors. Track Smart Money conviction in NGNE. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — NGNE

Based on 97 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q

For 3 consecutive quarters, more hedge funds added NGNE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

97 hedge funds hold NGNE right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

📶

Steady growth — +14% more funds vs a year ago

fund count last 6Q

+12 new funds entered over the past year (+14% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.

🟢

More buyers than sellers — 66% buying

63 buying32 selling

Last quarter: 63 funds were net buyers (18 opened a brand new position + 45 added to an existing one). Only 32 were sellers (17 trimmed + 15 sold completely). A clear majority buying is a strong confirmation signal.

➡️

Steady new buyers — ~18 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 11 → 15 → 16 → 18. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

📌

Mixed — 32% long-term, 25% new

■ 32% conviction (2yr+) ■ 43% medium ■ 25% new

Of the 97 current holders: 31 (32%) held >2 years, 42 held 1–2 years, and 24 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

📈

Growing discovery — still being found

16 → 11 → 15 → 16 → 18 new funds/Q

New funds entering each quarter: 11 → 15 → 16 → 18. A growing number of institutions are discovering NGNE each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

📊

Mixed cohorts — 22% veterans, 31% new entrants

■ 22% veterans ■ 47% 1-2yr ■ 31% new

Of 100 current holders: 22 (22%) held 2+ years, 47 held 1–2 years, 31 (31%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.

📋

Smaller funds dominant — 18% AUM from top-100

18% from top-100 AUM funds

32 of 95 holders rank in the top 100 by AUM, but together hold only 18% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

3.9

out of 10

Low Exit Risk

Exit risk score 3.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	96	94	2.13%
13F Shares	17M	17M	3.6%
Total Value	$345M	$341M	1.27%
New Positions	17	16	+1
Increased Positions	45	24	+21
Closed Positions	15	10	+5
Reduced Positions	16	29	-13
Total Calls	3	1	200.0%
Total Puts	2	0	100%
PUT/CALL Ratio	0.67	0.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

2.13%

13F Shares

17M

3.6%

Total Value

$345M

$341M

1.27%

New Positions

Increased Positions

+21

Closed Positions

Reduced Positions

-13

Total Calls

200.0%

Total Puts

100%

PUT/CALL Ratio

0.67

0.0

Bullish

Institutional Holders (2026 Q1)

96 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in NGNE. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 NGNE holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Trails Edge Capital Partners, LP	3.62%	782,787	$15.8M
2	Samsara BioCapital, LLC	3.36%	1,717,127	$34.6M
3	Great Point Partners LLC	2.32%	500,000	$10.1M
4	Casdin Capital, LLC	2.17%	1,420,361	$28.6M
5	Redmile Group, LLC	1.95%	1,459,599	$29.4M
6	EcoR1 Capital, LLC	1.09%	1,271,342	$25.6M
7	ArrowMark Colorado Holdings LLC	0.28%	524,796	$10.6M
8	Rtw Investments, LP	0.27%	1,362,456	$27.5M
9	DAFNA Capital Management LLC	0.26%	56,635	$1.1M
10	Rock Springs Capital Management LP	0.12%	104,339	$2.1M
11	Baker BROS. Advisors LP	0.11%	991,691	$20.0M
12	Virtus Investment Advisers, LLC	0.07%	13,033	$263K
13	Toronto Dominion Bank	0.02%	681,337	$13.7M
14	Balyasny Asset Management L.P.	0.02%	718,389	$14.5M
15	Raiffeisen Bank International AG	0.01%	43,000	$830K
16	Blair William & Co/Il	0.01%	168,218	$3.4M
17	XTX Topco Ltd	0.01%	27,431	$553K
18	AlphaQuest LLC	0.01%	7,215	$149K
19	Bridgeway Capital Management, LLC	0.01%	18,781	$379K
20	Jennison Associates LLC	0.01%	527,685	$10.6M
21	Woodline Partners LP	0.01%	83,835	$1.7M
22	Driehaus Capital Management LLC	0.00%	32,765	$661K
23	China Universal Asset Management Co., Ltd.	0.00%	2,749	$55K
24	Brevan Howard Capital Management LP	0.00%	12,754	$257K
25	Millennium Management LLC	0.00%	204,809	$4.1M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Neurogene Inc (NGNE)

What does the Smart Money Trend signal show for NGNE?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added NGNE than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for NGNE?

More buyers than sellers — 66% buying: Last quarter: 63 funds were net buyers (18 opened a brand new position + 45 added to an existing one). Only 32 were sellers (17 trimmed + 15 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for NGNE holders?

Smaller funds dominant — 18% AUM from top-100: 32 of 95 holders rank in the top 100 by AUM, but together hold only 18% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held NGNE?

Mixed — 32% long-term, 25% new: Of the 97 current holders: 31 (32%) held >2 years, 42 held 1–2 years, and 24 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Neurogene Inc (NGNE) following the 2026 Q1 hedge fund 13F filings?

As of today, NGNE has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), NGNE has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Neurogene Inc (NGNE)

Smart Money Signals — NGNE

Buying streak — 3 quarters in a row

At the ownership peak (100% of max)

Steady growth — +14% more funds vs a year ago

More buyers than sellers — 66% buying

Steady new buyers — ~18 new funds per quarter

Mixed — 32% long-term, 25% new

Growing discovery — still being found

Mixed cohorts — 22% veterans, 31% new entrants

Smaller funds dominant — 18% AUM from top-100

Institutional Sentiment Summary — NGNE

Hedge Fund Ownership: NGNE

Market Analysis: NGNE

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: NGNE

Is It Too Late to Buy Neurogene Inc (NGNE) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: NGNE

Statistics: NGNE

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — Neurogene Inc (NGNE)

Welcome to 13Foresight!